Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Machine Learning and Eye Movements Give Insights into Neurodegenerative Disease Mechanisms

Przybyszewski AW, Śledzianowski A, Chudzik A, Szlufik S, Koziorowski D.

Sensors (Basel). 2023 Feb 14;23(4):2145. doi: 10.3390/s23042145.

The Golgi Apparatus: A Voyage through Time, Structure, Function and Implication in Neurodegenerative Disorders

Mohan AG, Calenic B, Ghiurau NA, Duncea-Borca RM, Constantinescu AE, Constantinescu I.

Cells. 2023 Jul 31;12(15):1972. doi: 10.3390/cells12151972.

Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation

Zhang F, Liu M, Tuo J, Zhang L, Zhang J, Yu C, Xu Z.

Front Immunol. 2023 Oct 4;14:1253273. doi: 10.3389/fimmu.2023.1253273. eCollection 2023.

Nanoparticle Mediated Gene Therapy: A Trailblazer Armament to Fight CNS Disorders

Annu, Rehman S, Nabi B, Sartaj A, Md S, Sahoo PK, Baboota S, Ali J.

Curr Med Chem. 2023;30(3):304-315. doi: 10.2174/0929867329666220105122318.

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP.

Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903.

Neurotrophic factor-based pharmacological approaches in neurological disorders

Alfonsetti M, d'Angelo M, Castelli V.

Neural Regen Res. 2023 Jun;18(6):1220-1228. doi: 10.4103/1673-5374.358619.

Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders

Domínguez-Fernández C, Egiguren-Ortiz J, Razquin J, Gómez-Galán M, De Las Heras-García L, Paredes-Rodríguez E, Astigarraga E, Miguélez C, Barreda-Gómez G.

Int J Mol Sci. 2023 Feb 7;24(4):3321. doi: 10.3390/ijms24043321.

Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration

Kunze R, Fischer S, Marti HH, Preissner KT.

J Biomed Sci. 2023 Aug 7;30(1):64. doi: 10.1186/s12929-023-00954-y.

Overview on the Polyphenol Avenanthramide in Oats (Avena sativa Linn.) as Regulators of PI3K Signaling in the Management of Neurodegenerative Diseases

Wankhede NL, Kale MB, Bawankule AK, Aglawe MM, Taksande BG, Trivedi RV, Umekar MJ, Jamadagni A, Walse P, Koppula S, Kopalli SR.

Nutrients. 2023 Aug 27;15(17):3751. doi: 10.3390/nu15173751.

Anthropology of Deep Brain Stimulation; the 30th Anniversary of STN DBS in 2023

Hariz M, Blomstedt Y, Blomstedt P, Hariz GM.

Mov Disord Clin Pract. 2023 Sep 1;10(9):1285-1292. doi: 10.1002/mdc3.13858. eCollection 2023 Sep.

Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis

Kleine Bardenhorst S, Cereda E, Severgnini M, Barichella M, Pezzoli G, Keshavarzian A, Desideri A, Pietrucci D, Aho VTE, Scheperjans F, Hildebrand F, Weis S, Egert M, Karch A, Vital M, Rübsamen N.

Eur J Neurol. 2023 Nov;30(11):3581-3594. doi: 10.1111/ene.15671. Epub 2023 Jan 18.

The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases

Possemato E, La Barbera L, Nobili A, Krashia P, D'Amelio M.

Ageing Res Rev. 2023 Jun;87:101907. doi: 10.1016/j.arr.2023.101907. Epub 2023 Mar 8.

The Endo-lysosomal System in Parkinson's Disease: Expanding the Horizon

Muraleedharan A, Vanderperre B.

J Mol Biol. 2023 Jun 15;435(12):168140. doi: 10.1016/j.jmb.2023.168140. Epub 2023 May 4.

Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era

Surguchov A, Emamzadeh FN, Titova M, Surguchev AA.

Biomedicines. 2023 Apr 19;11(4):1215. doi: 10.3390/biomedicines11041215.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias